Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven M Hill

Showing results (21-30 of 72) with videos related to

Pageof 8
Sort By:
Steroids|June 19, 2010
Melatonin inhibits mitogenic cross-talk between retinoic acid-related orphan receptor alpha (RORalpha) and ERalpha in MCF-7 human breast cancer cellsChunmin Dong, Lin Yuan, Jun Dai, et al.
Journal of the American Association for Laboratory Animal Science : JAALAS|March 6, 2021
Effects of Daytime Blue-Enriched LED Light on Physiologic Parameters of Three Common Mouse Strains Maintained on an IVC SystemGeorge B Voros, Robert T Dauchy, Leann Myers, et al.
Journal of Pineal Research|August 19, 2008
The Galphai and Galphaq proteins mediate the effects of melatonin on steroid/thyroid hormone receptor transcriptional activity and breast cancer cell proliferationLing Lai, Lin Yuan, Qi Chen, et al.
Journal of Pineal Research|July 9, 2010
In vitro and in vivo antitumor activity of melatonin receptor agonistsLulu Mao, Qi Cheng, Béatrice Guardiola-Lemaître, et al.
Comparative Medicine|May 2, 2012
A new apparatus and surgical technique for the dual perfusion of human tumor xenografts in situ in nude ratsRobert T Dauchy, Erin M Dauchy, Lulu Mao, et al.
Breast Cancer Research and Treatment|June 16, 2010
Declining melatonin levels and MT1 receptor expression in aging rats is associated with enhanced mammary tumor growth and decreased sensitivity to melatoninSteven M Hill, Chi Cheng, Lin Yuan, et al.
Breast Cancer Research and Treatment|April 12, 2024
Retraction Note: Declining melatonin levels and MT1 receptor expression in aging rats is associated with enhanced mammary tumor growth and decreased sensitivity to melatoninSteven M Hill, Chi Cheng, Lin Yuan, et al.
Journal of Pineal Research|May 12, 2019
Epigenetic inhibition of the tumor suppressor ARHI by light at night-induced circadian melatonin disruption mediates STAT3-driven paclitaxel resistance in breast cancerShulin Xiang, Robert T Dauchy, Aaron E Hoffman, et al.
Cell Reports. Medicine|September 18, 2024
Mining nucleic acid "omics" to boost liquid biopsy in cancerAnn Tivey, Rebecca J Lee, Alexandra Clipson, et al.
Journal of Pineal Research|December 31, 2013
Molecular deficiency (ies) in MT₁ melatonin signaling pathway underlies the melatonin-unresponsive phenotype in MDA-MB-231 human breast cancer cellsLulu Mao, Lin Yuan, Shulin Xiang, et al.
Pageof 8

Showing results (21-30 of 72) with videos related to

Sort By:
Pageof 8
Steroids|June 19, 2010
Melatonin inhibits mitogenic cross-talk between retinoic acid-related orphan receptor alpha (RORalpha) and ERalpha in MCF-7 human breast cancer cellsChunmin Dong, Lin Yuan, Jun Dai, et al.
Journal of the American Association for Laboratory Animal Science : JAALAS|March 6, 2021
Effects of Daytime Blue-Enriched LED Light on Physiologic Parameters of Three Common Mouse Strains Maintained on an IVC SystemGeorge B Voros, Robert T Dauchy, Leann Myers, et al.
Journal of Pineal Research|August 19, 2008
The Galphai and Galphaq proteins mediate the effects of melatonin on steroid/thyroid hormone receptor transcriptional activity and breast cancer cell proliferationLing Lai, Lin Yuan, Qi Chen, et al.
Journal of Pineal Research|July 9, 2010
In vitro and in vivo antitumor activity of melatonin receptor agonistsLulu Mao, Qi Cheng, Béatrice Guardiola-Lemaître, et al.
Comparative Medicine|May 2, 2012
A new apparatus and surgical technique for the dual perfusion of human tumor xenografts in situ in nude ratsRobert T Dauchy, Erin M Dauchy, Lulu Mao, et al.
Breast Cancer Research and Treatment|June 16, 2010
Declining melatonin levels and MT1 receptor expression in aging rats is associated with enhanced mammary tumor growth and decreased sensitivity to melatoninSteven M Hill, Chi Cheng, Lin Yuan, et al.
Breast Cancer Research and Treatment|April 12, 2024
Retraction Note: Declining melatonin levels and MT1 receptor expression in aging rats is associated with enhanced mammary tumor growth and decreased sensitivity to melatoninSteven M Hill, Chi Cheng, Lin Yuan, et al.
Journal of Pineal Research|May 12, 2019
Epigenetic inhibition of the tumor suppressor ARHI by light at night-induced circadian melatonin disruption mediates STAT3-driven paclitaxel resistance in breast cancerShulin Xiang, Robert T Dauchy, Aaron E Hoffman, et al.
Cell Reports. Medicine|September 18, 2024
Mining nucleic acid "omics" to boost liquid biopsy in cancerAnn Tivey, Rebecca J Lee, Alexandra Clipson, et al.
Journal of Pineal Research|December 31, 2013
Molecular deficiency (ies) in MT₁ melatonin signaling pathway underlies the melatonin-unresponsive phenotype in MDA-MB-231 human breast cancer cellsLulu Mao, Lin Yuan, Shulin Xiang, et al.
Pageof 8